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PURPOSE. To investigate the effect of reducing high glucose (HG)-induced lysyl oxidase (LOX)
overexpression and increased activity on retinal endothelial cell apoptosis.
METHODS. Rat retinal endothelial cells (RRECs) were grown in normal (N) or HG (30 mM
glucose) medium for 7 days. In parallel, RRECs were grown in HG medium and transfected
with LOX small interfering RNA (siRNA), scrambled siRNA as control, or exposed to b-
aminopropionitrile (BAPN), a LOX inhibitor. LOX expression, AKT activation, and caspase-3
activity were determined by Western blot (WB) analysis and apoptosis by differential dye
staining assay. Moreover, to determine whether diabetes-induced LOX overexpression alters
AKT activation and promotes apoptosis, changes in LOX expression, AKT phosphorylation,
caspase-3 activation, and Bax expression were assessed in retinas of streptozotocin (STZ)-
induced diabetic mice and LOX heterozygous knockout (LOXþ/) mice.
RESULTS. WB analysis indicated significant LOX overexpression and reduced AKT activation
under HG condition in RRECs. Interestingly, when cells grown in HG were transfected with
LOX siRNA or exposed to BAPN, the number of apoptotic cells was significantly decreased
concomitant with increased AKT phosphorylation. Diabetic mouse retinas exhibited LOX
overexpression, decreased AKT phosphorylation, and increased Bax and caspase-3 activation
compared to values in nondiabetic mice. In LOXþ/ mice, reduced LOX levels were observed
with increased AKT activity, and reduced Bax and caspase-3 activity. Furthermore, decreased
levels of LOX in the LOXþ/ mice was protective against diabetes-induced apoptosis.
CONCLUSIONS. Findings from this study indicate that preventing LOX overexpression may be
protective against HG-induced apoptosis in retinal vascular cells associated with diabetic
retinopathy.
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Diabetic retinopathy, the leading cause of vision loss in theworking-age population,1,2 is characterized by early
vascular lesions such as the formation of acellular capillaries
(AC) and pericyte loss (PL),3–8 which can contribute to retinal
dysfunction. Studies suggest that retinal vascular basement
membrane (BM) thickening, a histologic hallmark of diabetic
retinopathy,9–12 may promote apoptosis and thus lead to
vascular cell loss.13–15 Our recent study suggests that lysyl
oxidase (LOX), a cross-linking enzyme critical for the develop-
ment and maturation of the BM, is upregulated in rat retinal
endothelial cells (RRECs) grown in high-glucose (HG) medium
and in diabetic rat retinas.16 Moreover, excess LOX has been
shown to be involved in promoting endothelial cell monolayer
permeability.16 However, the involvement of LOX in mediating
HG-induced apoptosis and subsequent retinal vascular cell loss
is not well understood.
LOX is synthesized as a 50-kD, N-glycosylated proenzyme
(pro-LOX), which undergoes proteolytic cleavage resulting in a
32-kD, catalytically active, and mature enzyme (LOX).17,18 The
integrity, stability, and functionality of the BM are largely
dependent on proper cross-linking of collagen as these cross-
links contribute to the physical and mechanical properties of
collagen fibrils in forming a stable BM assembly.19,20 LOX plays
a critical role in the posttranslational modification of collagen to
form covalent cross-links that stabilize insoluble collagen, thus
forming a functional extracellular matrix (ECM).21–23 However,
excess cross-linking mediated by LOX can lead to BM
thickening and compromised functionality due to the formation
of disorganized assembly of the collagen fibrils, promoting
abnormal ECM accumulation in fibrotic diseases.24,25 As the BM
undergoes histologic and biochemical changes induced by HG
insult, the development of AC and PL is exacerbated by the
abnormally thickened BM, ultimately progressing to early-stage
diabetic retinopathy.
While LOX is primarily known for its role in cross-linking,
recent studies indicate that increased LOX levels can promote
apoptosis. LOX upregulation may compromise the AKT
signaling pathway in human osteosarcoma cells and ras-
transformed NIH 3T3 cells,26,27 thereby promoting apoptosis.
LOX was also identified as a tumor suppressor gene,28,29 further
suggesting that LOX overexpression may trigger apoptosis.
However, it is currently unknown whether LOX overexpression
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promotes retinal vascular cell loss associated with diabetic
retinopathy.
The present study investigated whether HG-induced abnor-
mal LOX overexpression may contribute to apoptosis, and
whether reducing HG-induced LOX overexpression may
facilitate AKT pathway activity and thereby prevent apoptosis
in retinal endothelial cells. Additionally, to determine whether
changes seen in LOX expression under HG condition were
present in vivo, the retinas of LOXþ/ mice as well as those of
streptozotocin (STZ)-induced diabetic mice were examined.
METHODS
Cell Culture
Capillary endothelial cells derived from rat retinas (RRECs)
confirmed positive for von Willebrand factor (vWF) were used
in this study, and were isolated as previously described.30 To
determine the effect of abnormal LOX overexpression and
apoptosis, RRECs were grown in normal (N, 5 mM glucose) or
high-glucose (HG, 30 mM glucose) Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum (Sigma-
Aldrich Corp., St. Louis, MO, USA), antibiotics, and antimycot-
ics for 7 days. To determine the effect of reducing LOX
overexpression on cell viability, RRECs were grown in HG
medium and transfected with LOX small interfering RNA
(siRNA), or scrambled (Scram) siRNA as control. Cells from the
experimental groups were then assayed for LOX expression,
AKT activity, and caspase-3 activation.
Animals
All animal studies were performed in compliance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Twelve wild-type (WT) C57/BL6 albino male
mice (Harlan Lab, Inc., Indianapolis, IN, USA) and 12 LOXþ/
mice bred into the C57/BL6 albino background kindly
provided by Robert Mecham31 were used in the study.
Genotypes were determined by polymerase chain reaction
(PCR) at weaning using tail tip DNA, and then again at the time
animals were killed. PCR reactions were performed with a PCR
enzyme blend (PCR Master Mix; Promega, Madison, WI, USA)
and included the following primers: primer 1, 5 0-
ACGGCTTGTGTAACTGCAAA-30; primer 2, 50-TGAATGAACTG
CAGGACGAG-30; primer 3, 50-ATCTGAGTCCCGGTCTTCCT-30;
primer 4, 50-AGGTCCGGGAGACCTAAAGA-30. Primers 1 and 2
amplify an approximately 1500-bp fragment from the LOXþ/
allele. Primers 3 and 4 amplify a 1022-bp fragment from the
WT LOX allele. The LOX/ genotype was not used because it
is perinatal lethal.31,32
Six WT mice and six LOXþ/ mice were injected intraper-
itoneally with STZ (55 mg/kg body weight) to induce diabetes.
The glucose concentrations in blood and urine were checked
after 2 or 3 days following STZ injection to confirm diabetes
status in the animals. The remaining six WT and six LOXþ/
animals served as nondiabetic controls. Blood glucose levels
were measured in each animal two or three times weekly and
at the time of death. The diabetic group represented mice with
blood glucose levels of ~350 mg/dL. The diabetic mice
received neutral protamine Hagedorn (NPH) insulin injection
as needed to maintain blood glucose levels ~350 mg/dL. After
8 weeks of diabetes, all animals were killed, retinas were
isolated, and total protein was extracted. To examine the effect
of diabetes on LOX, AKT, phosphorylated AKT (p-AKT),
cleaved caspase-3, and Bax protein expression, protein isolated
from diabetic mouse retinas and nondiabetic mouse retinas
was subjected to Western blot (WB) analysis.
Cell Transfection With LOX siRNA and b-
Aminopropionitrile (BAPN) Treatment
To determine the effect of reduced LOX expression on cell
survival, RRECs were grown in HG medium and transfected
with 33 nM LOX siRNA (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), or 20 lM Scram siRNA (Qiagen, Valencia, CA, USA)
as a negative control in the presence of 8 lM Lipofectin
(Invitrogen, Carlsbad, CA, USA). In this study, an optimal
concentration of 33 nM LOX siRNA was used to achieve
approximately 40% reduction in LOX expression in RRECs, as
supported by our previous study.16 Additionally, to determine
whether LOX activity influences cell survival, cells were
exposed overnight to 500 lM BAPN (Sigma-Aldrich Corp.), a
potent inhibitor of LOX activity,33 24 hours prior to harvest.
Western Blot Analysis
To determine the expression of LOX, AKT, AKT phosphoryla-
tion, and caspase-3 activation, protein isolated from RRECs
grown in N or HG medium were subjected to WB analysis.
Similarly, protein samples isolated from diabetic or nondiabetic
mouse retinas were subjected to WB analysis to examine LOX,
AKT, AKT phosphorylation, cleaved caspase-3, and Bax
expression. RRECs grown in N or HG medium, or retinal
tissues of diabetic or nondiabetic mice, were washed with PBS
and lysed in buffer containing 10 mM Tris, pH 7.5 (Sigma-
Aldrich Corp.), 1 mM EDTA, and 0.1% Triton X-100 (Sigma-
Aldrich Corp.) to yield total protein. Lysates were centrifuged at
13,000g for 20 minutes at 48C. Protein samples from cell lysates
and retinal tissues were then measured by bicinchoninic acid
protein assay (Pierce Chemical, Rockford, IL, USA). An equal
amount of protein (20 lg) was loaded in each lane and
electrophoresed together with molecular weight standards (Bio-
Rad, Hercules, CA, USA) in separate lanes on a 10% SDS-
polyacrylamide gel. After electrophoresis, the proteins were
transferred onto PVDF membranes (Millipore, Billerica, MA,
USA) according to Towbin’s procedure34 using a semi-dry
apparatus. The membrane was blocked with 5% nonfat dry milk
for 2 hours and incubated overnight at 48C with rabbit
polyclonal LOX antibody (1:2000, Catalog No. NB110; Novus,
Littleton, CO, USA), rabbit polyclonal Ser473 phosphorylated
AKT (p-AKT) antibody (1:2000, Catalog No. 9271; Cell
Signaling, Danvers, MA, USA), AKT antibody (1:1000, Catalog
No. 9272; Cell Signaling), cleaved caspase-3 antibody (1:1000,
Catalog No. 9661; Cell Signaling), or Bax antibody (1:500,
Catalog No. 2772; Cell Signaling) solution in Tris-buffered saline
containing 0.1% Tween-20 (TTBS) and 5% BSA. The following
day, the membrane was washed with TTBS and incubated with
a secondary antibody solution containing anti-rabbit IgG, AP-
conjugated antibody (1:3000, Catalog No. 7054; Cell Signaling)
for 1 hour in room temperature. After washing with TTBS, the
membrane was subjected to Immun-Star chemiluminescent
substrate (Bio-Rad) and exposed to X-ray film (Fujifilm, Tokyo,
Japan). The amount of protein loaded in the gel lanes was
confirmed through Ponceau-S staining after transfer and by b-
actin antibody (1:1000, Catalog No. 4967; Cell Signaling). To
determine LOX, p-AKT, AKT, cleaved caspase-3, Bax, and b-actin
protein expression, densitometric analysis of the chemilumi-
nescent signal was performed at nonsaturating exposures and
analyzed using ImageJ software (developed by Wayne Rasband,
National Institutes of Health, Bethesda, MD, USA).
Differential Staining Assay to Identify Apoptotic
Cells
To identify apoptotic cells, a differential dye staining method35
was performed, which relies on the uptake of fluorescent dyes,
LOX and Apoptosis in Retinal Endothelial Cells IOVS j May 2017 j Vol. 58 j No. 5 j 2726
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/936209/ on 08/29/2017
acridine orange (AO) and ethidium bromide (EB).36 The
condition of the cell membrane integrity and the properties
of the DNA binding dyes facilitate the distinction of viable
versus early- or late-stage apoptotic cells.36 RRECs grown on
coverslips as specified in the experimental conditions were
exposed to a dye mixture containing 25 lg/mL ethidium
bromide (Catalog No. E-8751; Sigma-Aldrich Corp.) and 25 lg/
mL acridine orange (Catalog No. A-6014; Sigma-Aldrich Corp.)
for 10 minutes, washed with PBS, fixed, and mounted in
SlowFade Antifade Kit (Catalog No. S2828; Invitrogen, Eugene,
OR, USA). The cells were then visualized using a 4 0,6-
diamidino-2-phenylindole (DAPI) filter, and imaged using a
digital camera attached to a fluorescence microscope (Nikon
Diaphot, Tokyo, Japan). Ten random fields of approximately
1000 cells/field per sample were counted. Data are pooled
from four independent experiments. The number of apoptotic
cells per field was expressed as a percentage of the total
number of cells in the field, also known as the apoptotic
index.36 Apoptotic cells appear orange or bright green while
viable cells appear uniformly dark green.
Statistical Analysis
All data are expressed as mean 6 standard deviation (SD).
Values of the control groups were normalized to 100%, and
values from all other groups were expressed as percentages of
control. Statistical analysis was performed using the normalized
values. Comparisons between groups were performed using 1-
way ANOVA followed by Bonferroni’s post hoc test. A level of P
< 0.05 was considered statistically significant.
RESULTS
Effect of HG on LOX Protein Expression in RRECs
RRECs grown in HG medium had significantly increased LOX
expression compared to cells grown in N medium (163 6 23%
of N versus 100 6 17% of N; P < 0.05; n¼ 4; Figs. 1A, 1B). In
addition, cells grown in HG medium and transfected with LOX
siRNA showed significantly reduced LOX expression compared
to cells grown in HG alone (124 6 8% of N versus 163 6 23%
of N; P < 0.05; n¼4; Figs. 1A, 1B). As expected, cells grown in
HG medium transfected with Scram siRNA did not show a
significant difference in LOX expression compared to cells
grown in HG medium alone (165 6 12% of N versus 163 6
23% of N; P > 0.05; n¼ 4; Figs. 1A, 1B).
Effect of HG and LOX Downregulation on AKT
Activity and Caspase-3 Activation in RRECs
Western blot analysis indicated that the ratio of p-AKT to total
AKT was significantly decreased in cells grown in HG
medium compared to those grown in N medium (65.8 6
12.3% of N versus 100 6 7.01% of N, P < 0.05; n ¼ 4; Figs.
1A, 1C). Interestingly, reducing LOX overexpression im-
proved the ratio of p-AKT to AKT, indicating that AKT
activity was restored. Cells grown in HG medium and
transfected with LOX siRNA showed a significantly improved
ratio of p-AKT to AKT compared to cells grown in HG alone
(90.1 6 12.9% of N versus 65.8 6 12.3% of N; P < 0.05; n¼
4; Figs. 1A, 1C). As expected, cells grown in HG medium
transfected with Scram siRNA did not show a significant
difference in the ratio of p-AKT to AKT compared to cells
grown in HG medium alone (68.9 6 11.4% of N versus 65.8
6 12.3% of N; P > 0.05; n¼ 4; Figs. 1A, 1C). Moreover, cells
grown in HG medium exhibited significantly increased
caspase-3 activation (153.0 6 27.1% of N; P < 0.05; n ¼ 4;
Figs. 1A, 1D). Importantly, cells grown in HG medium and
transfected with LOX siRNA showed reduced caspase-3
activation compared to cells grown in HG medium (102.3
6 11.4% of N; P < 0.05; n ¼ 4; Figs. 1A, 1D).
Reduced LOX Expression and Activity Protect
Against HG-Induced Apoptosis in RRECs
Differential dye staining indicated that the cells grown in HG
medium showed significantly increased number of apoptotic
cells compared to those grown in N medium (4.10 6 0.53 cells
per 100 cells versus 1.83 6 0.14 cells per 100 cells; P < 0.05; n
¼ 4; Figs. 2A, 2B, 2E). Interestingly, cells grown in HG medium
transfected with LOX siRNA exhibited a significantly reduced
number of apoptotic cells compared to cells grown in HG
medium alone (2.74 6 0.26 cells per 100 cells versus 4.10 6
0.53 cells per 100 cells; P < 0.05; n ¼ 4; Figs. 2B, 2C, 2E).
RRECs grown in HG medium transfected with Scram siRNA did
not show a significant difference in the number of apoptotic
cells compared to cells grown in HG medium alone (4.15 6
0.16 cells per 100 cells versus 4.10 6 0.53 cells per 100 cells; P
> 0.05; n ¼ 4; Figs. 2C, 2D, 2E).
Reduced LOX Activity Rescues AKT Activity and
Protects Against HG-Induced Apoptosis in RRECs
To determine whether reduced LOX activity alters AKT activity
and influences cell survival, WB analysis and differential dye
staining assay were performed. Interestingly, cells grown in HG
medium and exposed to BAPN exhibited a significant increase
in the ratio of p-AKT to total AKT compared to cells grown in
HG medium alone (63.0 6 10.9% of N versus 44.1 6 8.5% of
N; P < 0.05; n¼ 4; Figs. 3A, 3B). Differential dye staining data
indicated that cells grown in HG medium showed a signifi-
cantly increased number of apoptotic cells compared to those
grown in N medium (3.16 6 0.39 cells per 100 cells versus
1.38 6 0.40 cells per 100 cells; P < 0.05; n ¼ 4; Figs. 4A, 4B,
4D). Furthermore, cells grown in HG medium and exposed to
BAPN exhibited significantly reduced number of apoptotic
cells compared to cells grown in HG medium alone (2.12 6
0.52 cells per 100 cells versus 3.16 6 0.39 cells per 100 cells; P
< 0.05; n ¼ 4; Figs. 4B, 4C, 4D).
Reducing Diabetes-Induced LOX Overexpression
Restores AKT Activity and Inhibits Apoptosis in
Mouse Retinas
To determine the effect of diabetes on LOX expression and
AKT activity in diabetic mouse retinas, and also whether
reducing diabetes-induced LOX overexpression alters AKT
activity and caspase-3 activation in diabetic LOXþ/ mouse
retinas, WB was performed. As expected, WB analysis revealed
that the diabetic mouse retinas showed a significant increase in
LOX expression compared to nondiabetic mouse retinas (145
6 21% of WT versus 100 6 30% of WT, P < 0.05; n ¼ 6;
Figs. 5A, 5B). Additionally, the LOXþ/ mice showed a decrease
in retinal LOX levels compared with those of control mice (64
6 13% of WT versus 100 6 30% of WT, P < 0.05; n¼ 6; Figs.
5A, 5B). Importantly, diabetic mouse retinas exhibited a
significant decrease in the ratio of p-AKT to total AKT (56.5
6 19% of WT versus 100 6 9.7% of WT, P < 0.05; n ¼ 6;
Figs. 5A, 5C) as well as a significant increase in cleaved caspase-
3 expression (181 6 31% of WT versus 100 6 20% of WT, P <
0.05; n ¼ 6; Figs. 5A, 5D) and Bax expression (150 6 14% of
WT versus 100 6 23% of WT, P < 0.05; n ¼ 6; Figs. 5A, 5E)
compared to nondiabetic mouse retinas. Interestingly, reducing
LOX overexpression improved the ratio of p-AKT to AKT,
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indicating that AKT activity was restored. Retinas of diabetic
LOXþ/ mice showed a significantly improved ratio of p-AKT to
AKT (77.5 6 12% of WT versus 56.5 6 19% of WT; P < 0.05; n
¼ 6; Figs. 5A, 5C) as well as decreased cleaved caspase-3
expression (115 6 6% of WT versus 181 6 31% of WT; P <
0.05; n¼ 6; Figs. 5A, 5D) and reduced Bax expression (114 6
18% of WT versus 150 6 14% of WT; P < 0.05; n¼ 6; Figs. 5A,
5E) compared to diabetic mouse retinas.
DISCUSSION
The present study demonstrates that retinal endothelial cells
grown in HG medium exhibit abnormal LOX overexpression
and decreased AKT phosphorylation concomitant with cas-
pase-3 activation. Similarly, retinas of diabetic mice show LOX
upregulation, compromised AKT phosphorylation, and cas-
pase-3 and Bax activation. Interestingly, when LOX upregu-
FIGURE 1. Effects of HG and LOX downregulation on AKT activity in RRECs. (A) Representative WB image shows that LOX expression is
significantly increased in HG condition. The ratios of p-AKT to AKT were significantly decreased in cells grown in HG medium and in cells grown in
HG medium transfected with Scram siRNA. Interestingly, reducing LOX overexpression improved the ratio of p-AKT to AKT. (B) Graphic illustration
of cumulative data shows that LOX siRNA significantly reduced LOX expression. (C) Graphic illustration of cumulative data shows ratios of p-AKT to
AKT significantly increased in cells grown in HG medium transfected with LOX siRNA compared to cells grown in HG medium or cells grown in HG
medium transfected with Scram siRNA. (D) Graphic illustration of cumulative data shows that LOX siRNA significantly reduced cleaved caspase-3
expression. Data are expressed as mean 6 SD. *N versus HG; P < 0.05. **HGþLOX siRNA versus HGþScram siRNA; P < 0.05. n¼ 4.
FIGURE 2. LOX downregulation protects RRECs from HG-induced apoptosis. (A–D) Representative images of cells undergoing apoptosis (arrows):
(A) Normal, (B) HG, (C) HGþLOX siRNA, (D) HGþScram siRNA. Scale bar: 50 lm. Differential staining assay shows that cells under HG condition
undergo increased apoptosis, which was prevented by reducing LOX overexpression. (E) Graphic illustration of cumulative data shows that
downregulation of LOX expression rescues RRECs from HG-induced apoptosis. Data are expressed as mean 6 SD. *N versus HG; P < 0.05.
**HGþLOX siRNA versus HGþScram siRNA; P < 0.05. n¼ 4.
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lation is reduced to near normal levels using LOX siRNA or
when LOX level is decreased due to allele knockout strategies,
such as the LOXþ/ mice used in the current study, we
observed restoration of AKT activity, suggesting a direct link
between LOX expression and AKT activation. In addition,
when HG-induced increased LOX activity was reduced using
BAPN, AKT activity was improved. To our knowledge, this is
the first study showing that HG-mediated increased LOX
expression and activity inactivate AKT signaling, which
triggers caspase-3 activation, thereby promoting apoptosis in
RRECs, and that reducing abnormal LOX overexpression and
increased activity improves AKT activation, protecting RRECs
from HG-induced apoptosis. Moreover, this finding is support-
ed by previous studies indicating that LOX upregulation
impairs AKT activity26,27 contributing to apoptosis. These
results derived from an in vitro model of hyperglycemia, a STZ-
induced diabetes animal model, and a LOXþ/ animal model,
suggest that abnormal LOX upregulation may play an important
role in promoting the development of retinal vascular lesions
associated with diabetic retinopathy.
Previously, we have shown that LOX expression is
significantly increased in retinal endothelial cells under HG
condition and in retinas of diabetic rats.16 Furthermore, our
previous data suggest that increased LOX activity may lead to
excessive cross-linking resulting in compact collagen fibrils,
which in turn may compromise the ultrastructural integrity of
the BM.16 Importantly, we have identified that HG-induced
increase in LOX activity promotes excess cell monolayer
permeability in retinal endothelial cells,16 providing a potential
mechanistic insight into vascular leakage associated with
thickened BM seen in diabetic retinopathy. While the
association between LOX and formation of the BM is well
established, the relationship between LOX overexpression and
retinal vascular cell loss is unclear. The current study shows for
the first time that excess LOX levels play a critical role in
triggering apoptosis and thereby promote retinal vascular cell
loss.
Decreased AKT activity under HG or diabetic condi-
tions37–40 leads to apoptosis.37,38,40 Importantly, findings from
the current study indicate that HG-induced LOX upregulation
leads to reduced AKT-Ser473 phosphorylation, promoting
apoptosis. However, the exact mechanism of action mediating
these changes underlying upregulated LOX expression is
currently not well known. A study by Jeay et al.26 suggests
that LOX inhibits Ras signaling and prevents recruitment of
AKT to the plasma membrane necessary for AKT activation.
Another study reported that adenovirus-mediated LOX upreg-
ulation blocked AKT activation, promoting apoptosis.27 Fur-
thermore, LOX inhibition prevented apoptosis in volume
overloaded hearts of rats.41 It is also interesting to note that
LOX pro-peptide (LOX-PP), an 18-kD domain of LOX produced
during proteolytic cleavage, can promote apoptosis by AKT
inactivation.42 Therefore, it is conceivable that LOX-PP may
also play a contributory role in triggering apoptosis under HG
conditions. Taken together, these results indicate that HG-
induced LOX upregulation may contribute to retinal vascular
cell apoptosis, at least in part, by impairing AKT activation
necessary for cell survival.
The role of LOX in maintaining retinal homeostasis and cell
survival is only beginning to be understood. Interestingly, a
recent study by Yang et al.43 showed that LOX inhibition was
associated with reduced nuclear factor–jB (NF-jB) activation.
Importantly, NF–jB activation has been shown to promote
apoptosis in the context of diabetic retinopathy.44–46 Further-
more, HG-induced AKT inactivation can lead to reduced nitric
oxide production,37 which can inhibit proapoptotic NF-jB
signaling.37 These findings indicate that HG can lead to
sustained NF–jB activation and reduce AKT signaling in
endothelial cells, thereby contributing to vascular cell loss.37
These cellular events may provide insight into a potential
mechanism by which normalizing LOX expression may restore
AKT activity, and thereby promote cell survival by inhibiting
the proapoptotic NF–jB signaling in retinal endothelial cells.
FIGURE 3. Inhibiting increased LOX activity rescues AKT signaling in
RRECs. (A) Representative WB image shows that the ratio of p-AKT to
AKT was significantly decreased in cells grown in HG medium.
Interestingly, inhibiting HG-induced increased LOX activity significantly
increased the ratio of p-AKT to AKT. (B) Graphic illustration of
cumulative data shows ratios of p-AKT to AKT significantly increased in
cells grown in HG medium treated with BAPN compared to cells
grown in HG medium alone. Data are expressed as mean 6 SD. *N
versus HG; P < 0.01. **HG versus HGþBAPN; P < 0.05. n ¼ 4.
FIGURE 4. BAPN treatment prevents HG-induced apoptosis. (A–C)
Representative images of cells undergoing apoptosis (arrows): (A)
Normal, (B) HG, (C) HGþBAPN. Scale bar: 50 lm. Differential staining
assay shows that inhibition of HG-induced increased LOX activity via
BAPN treatment reduced the number of cells undergoing apoptosis.
(D) Graphic illustration of cumulative data shows that inhibiting HG-
induced increased LOX activity rescues RRECs from HG-induced
apoptosis. Data are expressed as mean 6 SD. N versus HG; P < 0.05.
**HG versus HGþBAPN; P < 0.05. n¼ 4.
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Findings from the current study suggest that HG-induced
LOX overexpression contributes to accelerated cell loss
associated with early-stage diabetic retinopathy, at least in part
by AKT inactivation. These findings may offer an insight into
potential mechanisms by which HG promotes apoptosis. The
present study demonstrated that blocking HG-induced LOX
upregulation might have beneficial effects including preven-
tion of retinal vascular cell loss associated with diabetic
retinopathy. Therefore, targeting LOX overexpression and/or
increased activity could be a useful strategy for preventing
vascular cell loss in diabetic retinopathy.
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